knowledge -WSS

knowledge

author：Wikipedia 2025-09-01 04:26:37 - browse：928

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： H.R. 3 is the wrong path to lower drug costs

leisure time

focus

WSS

Mass General Brigham physicians react to latest merger step

U.K. decision on ALS drug has neurologists, advocates up in arms

Medicare slashes safety net hospital payments by nearly $1 billion

Medicare slashes safety net hospital payments by nearly $1 billion

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

'Null' research findings aren't empty of meaning. Let's publish them

leisure time

knowledge

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

FDA scientists endorse Pfizer/BioNTech Covid

What does generative AI mean for health care? We asked experts

Group behind ProMed defends move to subscription

Virginia high school admissions case could be legal follow

Four alarming medical procedures we’re glad history forgot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mass General Brigham physicians react to latest merger step

Wildfire smoke exposes gaps in outdoor worker protections

Florida Supreme Court upholds state's abortion ban

focus

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

When waiting feels immoral: Empathy in the emergency department

When waiting feels immoral: Empathy in the emergency department

People with mental disorders often marry others with same

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Study: Black kids more likely to die after surgery than white kids

entertainment

leisure time

focus

leisure time